Mortality and morbidity in patients with central retinal vein occlusion.
We investigated the risk of mortality and morbidity in 78 patients with central retinal vein occlusion (CRVO) followed for more than 2 years (mean follow-up 7.2 years). Thirteen subjects died at an average of 7.0 years after CRVO. Five subjects developed myocardial infarction at an average of 2.8 years after CRVO, and 1 developed a cerebrovascular accident 3 years after CRVO. Patients with CRVO do not carry a higher risk of mortality and morbidity than matched controls derived from national surveys.
Mansour
A M
AM
Department of Ophthalmology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, N.Y.
Walsh
J B
JB
Henkind
P
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002561:Cerebrovascular Disorders / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D009203:Myocardial Infarction / Q000453:epidemiology; D009518:New York / Q000453:epidemiology; D012170:Retinal Vein Occlusion / Q000453:epidemiology* / Q000401:mortality; D012307:Risk Factors